Form 4: GeneDx Holdings CFO Kevin Feeley Executes Stock Transactions

GeneDx Holdings CFO Kevin Feeley acquired shares through restricted stock unit vesting and sold shares to cover tax obligations.

Summary

• Kevin Feeley, the Chief Financial Officer of GeneDx Holdings Corp., engaged in stock transactions.
• On December 1, 2024, 718 shares of Class A Common Stock were acquired through the vesting of restricted stock units (RSUs) at a price of $0.
• On December 2, 2024, 263 shares of Class A Common Stock were sold at a price of $78.3912 per share.
• The sale of shares was to cover tax withholding obligations related to the vesting of the RSUs.
• Following these transactions, Mr. Feeley directly owns 23,406 shares of Class A Common Stock and 5,021 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and expected for executive compensation. There is no indication of positive or negative sentiment from the transactions themselves.

Positives

• The vesting of restricted stock units indicates a form of compensation and alignment of interests with the company's performance.

Negatives

• The sale of shares, while for tax purposes, could be perceived negatively by some investors as a reduction in the officer's direct holdings.

Risks

• Executive stock sales, even for tax purposes, can sometimes be misinterpreted by the market, potentially leading to short-term price volatility.
• The timing of the sale could be viewed as opportunistic, although it is a standard practice for RSU vesting.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• The vesting schedule of 6.25% quarterly over four years is a fairly standard vesting schedule for RSU grants in the technology and biotech industries.
• The 'sell to cover' transaction is a common practice among executives to manage tax liabilities associated with equity compensation. Companies like Illumina, Exact Sciences, and Invitae also have executives who regularly engage in similar transactions.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they are related to executive compensation and tax obligations.
• The sale of shares could slightly increase the supply of shares in the market.

Key Dates

Keywords

GeneDx Holdings, Kevin Feeley, CFO, stock transaction, restricted stock units, RSU, insider trading, tax withholding, Class A Common Stock